Clinical Trial Update: Proton Pump Inhibitor (PPI) Response in Eosinophilic Esophagitis Assessed by Transnasal Endoscopy (TNE) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating proton pump inhibitor response in eosinophilic esophagitis using transnasal endoscopy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Esophagitis

Drugs mentioned

• Proton Pump Inhibitor (proton pump inhibitor)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Eosinophilic Esophagitis | Phase 4 | Status: ACTIVE_NOT_RECRUITING